Breaking News
June 19, 2018 - Innovative drugs and new European treatment guidelines refine, improve MS therapy
June 19, 2018 - BIDMC scientists develop new tool to benefit patients with HCV-associated liver failure
June 19, 2018 - Diabetes diagnosis may come with increased risk of pancreatic cancer for African-Americans, Latinos
June 19, 2018 - Personalized Goals, Cash Motivate Heart Patients to Exercise
June 19, 2018 - Nipah Virus (NiV) | CDC
June 19, 2018 - Genomics offers new treatment options for infants with range of soft tissue tumors
June 18, 2018 - Study shows how moderate consumption of alcohol can protect the heart
June 18, 2018 - Gene editing technology predicts heart disease risk
June 18, 2018 - Who Will and Who Won’t Get the Flu?
June 18, 2018 - Research shows effective responses to online feedback
June 18, 2018 - Scientists to focus on big data and genetics to identify risk factors for dementia
June 18, 2018 - Ultrasound-based technology for assessing overweight adolescents with liver disease
June 18, 2018 - Osteochondral knee defect treated using cell technology
June 18, 2018 - Study demonstrates increased levels of gum disease in people at risk of rheumatoid arthritis
June 18, 2018 - Ebola & Marburg | NIH: National Institute of Allergy and Infectious Diseases
June 18, 2018 - Brains, eyes, testes: off-limits for transplants?
June 18, 2018 - Drug used to treat myelofibrosis can awaken ‘dormant’ lymphomas in the bone marrow
June 18, 2018 - New study focuses on best, cost effective practices to bridge treatment gap for brain disorders
June 18, 2018 - New study highlights predictors that prevent from achieving remission in early RA
June 18, 2018 - Study highlights potential use of blood biomarkers as diagnostic tool for sleep apnea
June 18, 2018 - Eating plant-based diet can reduce risk for heart problems in people with type 2 diabetes
June 18, 2018 - Lenabasum has acceptable safety and tolerability in diffuse cutaneous systemic sclerosis
June 18, 2018 - Study shows link between risky opioid prescriptions and increased odds of death
June 18, 2018 - Bone density scans could help determine likelihood of cardiovascular disease
June 18, 2018 - Mechanical thrombectomy appears to be important therapy for acute stroke in very old patients
June 18, 2018 - Novel compound as effective as FDA-approved antibiotics for treating deadly infections
June 18, 2018 - Ironwood Pharmaceuticals Announces FDA Orphan Drug Designation for Olinciguat for the Treatment of Sickle Cell Disease
June 18, 2018 - Surgical outcomes equivalent whether physician anesthesiologist assisted by nurse anesthetist or AA
June 18, 2018 - Studies provide insight into molecular changes prior to onset of arthritis
June 18, 2018 - Dyaco unveils specialist medical and rehabilitation equipment range in the UK
June 18, 2018 - Engineers develop algorithm to monitor joints of patients with arthritis
June 18, 2018 - Women with higher vitamin D blood levels have lower risk for breast cancer
June 18, 2018 - New studies help elucidate role of sleep in chronic pain
June 18, 2018 - Researchers link red meat sensitivity spread by ticks with heart disease
June 18, 2018 - Research explores role of autopsy in cardiovascular medicine
June 18, 2018 - Motif Bio Submits NDA for Iclaprim
June 18, 2018 - NIH-funded researchers identify target for chikungunya treatment
June 18, 2018 - Negative emotions are murkier, less distinct in adolescence
June 18, 2018 - Gut microbiome may be potential contributor to depression, anxiety in people with obesity
June 18, 2018 - Canakinumab reduces gout rate by more than half in atherosclerosis patients, study shows
June 18, 2018 - What Does the Future Hold?
June 18, 2018 - FDA Approves Keytruda (pembrolizumab) for Treatment of Refractory or Relapsed Primary Mediastinal Large B-Cell Lymphoma (PMBCL)
June 18, 2018 - School cliques don’t always click
June 18, 2018 - Three experts from The Tinnitus Clinic contribute to major review on pulsatile tinnitus
June 18, 2018 - Unwieldy health costs often stand between teachers and fatter paychecks
June 18, 2018 - Link between frailty and mortality remains unchanged despite lower death rates, study finds
June 18, 2018 - Sleep disorders appear to be first sign of serious neurological diseases
June 18, 2018 - Childhood, adult obesity raise risk of developing hip and knee osteoarthritis
June 18, 2018 - Study unravels ‘blood stem cell niche’ puzzle
June 18, 2018 - People with heart problems do not take enough exercise, shows study
June 18, 2018 - Strong Link Identified Between T2DM and Parkinson’s Disease
June 18, 2018 - Early childhood interventions show mixed results on child development
June 18, 2018 - Chronic use of opioids related to increased risk of fracture nonunion
June 18, 2018 - AHA: Family Perseveres After Losing Father to Heart Attack
June 18, 2018 - Oral propranolol seems safe for infantile hemangioma
June 18, 2018 - New study gives explanation for food’s prominence in memory
June 18, 2018 - First photoactive drug to fight Parkinson’s disease
June 18, 2018 - Patient’s self-evaluation of personality disorders not as far off as previously perceived
June 18, 2018 - Upadacitinib Monotherapy Meets All Primary and Ranked Secondary Endpoints Versus Methotrexate in a Phase 3 Study in Rheumatoid Arthritis
June 18, 2018 - Vitamin B3 has a positive effect on damaged nerve cells in Parkinson’s patients
June 17, 2018 - Sunovion Announces FDA Acceptance of New Drug Application for Apomorphine Sublingual Film (APL-130277)
June 17, 2018 - Bid to beat obesity focuses on fat that keeps us warm
June 17, 2018 - Work Stress May Increase Risk of Developing Atrial Fibrillation
June 17, 2018 - New Zealand’s secret recipe for active school travel: The neighborhood built environment
June 17, 2018 - New Medscape report reveals sexual harassment rate of physicians
June 17, 2018 - Surgical Blood Transfusions Tied to Clot Risk
June 17, 2018 - CDC chief makes $375K, far exceeding his predecessors’ pay
June 17, 2018 - Education linked to higher risk of short-sightedness
June 17, 2018 - Patients with Moderate-to-Severe Ulcerative Colitis Achieved Clinical and Endoscopic Remission with Mirikizumab in Phase 2 Trial
June 17, 2018 - UA registers a more customised multifocal lens to correct presbyopia
June 17, 2018 - U.S. FDA and European Medicines Agency Accept Regulatory Submissions for Review of Talazoparib for Metastatic Breast Cancer Patients with an Inherited BRCA Mutation
June 17, 2018 - Vaginal estrogen tablets, moisturizers and placebo gel all can improve vaginal discomfort
June 17, 2018 - Addition of Bezafibrate Beneficial in Primary Biliary Cholangitis
June 17, 2018 - Radiation Therapy for Cancer – National Cancer Institute
June 17, 2018 - Technology could help pregnant women detect health complications
June 17, 2018 - Study finds drop in frequent use of ED after Affordable Care Act
June 17, 2018 - Do Antipsychotic Meds for Kids Raise Diabetes Risk?
June 17, 2018 - New light shed on mechanisms of paediatric epilepsy
June 17, 2018 - People who deeply grasp the pain or happiness of others also process music differently in the brain
June 16, 2018 - Scientists discover how cancer-targeting ‘Natural Killer’ cells are fueled in the body
Researchers show association between microbiome and cancer-related blood infections

Researchers show association between microbiome and cancer-related blood infections

image_pdfDownload PDFimage_print

Cancer patients receive essential medicines, fluids, blood and nutrients through long, flexible tubes called central venous catheters, or central lines. But every year in the United States, these central lines are associated with an estimated 400,000 blood infections, many of which are fatal, and which cost the healthcare system upwards of $18 billion dollars annually. But what if some or even many of these infections aren’t, in fact, introduced by central lines? A study by University of Colorado Cancer Center investigators working at Children’s Hospital Colorado and published in the journal PLoS ONE explores another possible cause of cancer-associated blood infections, namely changes in the microbiome, the community of microorganisms that live within the human body. It may be that an imbalanced microbiome along with a leaky gut and not an unhygienic central line is the cause of some bloodstream infections.

“Basically, we wanted to see if the composition of a cancer patient’s microbiome could predict who would go on to develop bloodstream and Clostridium difficile infections,” says Bryan Nycz, third year medical student at the CU School of Medicine and the paper’s first author. Nycz worked with CU investigators Daniel Frank, PhD (a microbiome expert in the CU School of Medicine Division of Infectious Diseases), Samuel Dominguez, MD, PhD (pediatriac infectious disease specialist and medical director of the clinical microbiology laboratory at Children’s Hospital Colorado) and Joanne Hilden, MD (director of clinical services for hematologic oncology at Children’s Hospital Colorado), among others.

The study took advantage of samples collected during a 2012 outbreak of Clostridium difficile (C. diff). From October through December of that year, stool samples were collected from all pediatric oncology patients admitted to Children’s Hospital Colorado, to check for C. diff colonization. Some of these patients subsequently developed C. diff infections and, unfortunately but as expected, some developed blood infections. The fact that stool samples were preserved allowed the current study to explore the link between the composition of patients’ microbiomes (via the microorganisms identified in stool) and these two types of infection.

In all, samples and records were available for 42 patients.

First, in this population, the composition of the microbiome differed based on a patient’s type of cancer and type of treatment – in other words (and as expected), the location and type of cancer, along with cancer treatments like chemotherapy and antibiotics, affected the diversity and makeup of patients’ microbiomes. Also as researchers expected, the microbiomes of patients who had received bone marrow transplants and subsequent therapies were most affected.

Second, the composition of a patient’s microbiome did not necessarily predict which patients would develop C. diff infections. However, Nycz points out that the relatively small sample size may have contributed to not discovering a significant connection between microbiome composition and C. diff infection.

“Although our results did not demonstrate a connection between the microbiome and C. diff infections, our data did hint there might be an association,” he says. (An ongoing study hopes to add additional data.)

Third, however, the composition of a patient’s microbiome did, in fact, predict whether that patient would develop a blood infection. Specifically, the six patients who developed bloodstream infections had significantly reduced microbiome diversity than patients who remained free of infection. Additionally, when Nycz and his scientific mentors examined the types of bacteria implicated in these infections, three of the six patients who developed bloodstream infections had been infected with types of bacteria that were specifically abundant in their microbiome samples.

“We’re proposing ‘here’s what they have in their bloodstream’, and ‘here’s where the microorganism may have come from’ i.e. their gut,” Nycz says.

Historically, the widely-accepted term for this type of infection in pediatric oncology patients is “central line associated bloodstream infection” or CLABSI. However, the current study argues that not all bloodstream infections in this population are introduced via central lines and that CLABSI may thus be an inaccurate term to describe these infections.

“We can’t attributew all of these infectiosn to poor central line hygiene,” says Nycz. “We should shy away from calling these infections CLABSI and start referring to them more generally as bloodstream infections.”

The implication is that appropriate prevention and treatment may depend on the source of infection. If some infections previously called CLABSI are, in fact, due to microbial populations leaking into the bloodstream from the gut (“leaky gut” is especially common in cancer patients), then prevention may depend on maintaining microbiome health, and treatment could include strategies that therapeutically adjust the microbiome. Likewise, patients with altered microbiomes may benefit from closer monitoring for infections.

“It’s way too early to suggest that pediatric oncologists make predictions or manipulate patients’ microbiomes,” says Nycz. “But our results add to a growing body of literature suggesting that the microbiome matters during cancer treatment. In this case, microbiome diversity and composition may help us identify patients at greater risk for blood infections.”

As part of the CU School of Medicine Research Track, Nycz will continue studying the link between the microbiome and infection in pediatric cancer patients. The next phase of this ongoing study follows patients for a year after hospital admission to determine how the microbiome changes over time in response to cancer and cancer treatment, and to examine more closely whether changes in the microbiome can predict the development of C. diff and/or bloodstream infections.

Source:

http://www.coloradocancerblogs.org/microbiome-predicts-blood-infections-pediatric-cancer-patients/

Tagged with:

About author

Related Articles